MaxCyte, Inc.MXCTNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank8
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P8
Near historical low
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-9.32%
Q3 2025-28.33%
Q2 2025-2.52%
Q1 20253.98%
Q4 2024-1.96%
Q3 2024-2.13%
Q2 2024-1.47%
Q1 2024-5.33%
Q4 202310.21%
Q3 2023-1.65%
Q2 20232.20%
Q1 202325.11%
Q4 20220.68%
Q3 2022-8.99%
Q2 202214.92%
Q1 20224.10%
Q4 202113.48%
Q3 202117.63%
Q2 202130.21%
Q1 202113.54%
Q4 202017.12%
Q3 202026.58%
Q2 2020-10.15%
Q1 202021.83%
Q4 2019-14.49%
Q3 201911.42%
Q2 20190.00%
Q1 20195.35%
Q4 20180.00%
Q3 20188.87%
Q2 20180.00%
Q1 201810.88%
Q4 20170.00%
Q3 2017-3.16%
Q2 20170.00%
Q1 20173.14%
Q4 20160.00%
Q3 201636.67%
Q2 20160.00%
Q1 201621.43%